Showing 1191-1200 of 1354 results for "".
The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action
https://practicalneurology.com/programs/cme/the-science-behind-fcrn-antagonists-a-deep-dive-into-their-mechanism-of-action/32241/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid
https://practicalneurology.com/programs/cme/balancing-risk-and-benefit-traditional-mg-treatments-and-medications-to-avoid/32240/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Bridging the Gap: How Online Patient Discussions Can Transform Narcolepsy Care
https://practicalneurology.com/diseases-diagnoses/sleep/bridging-the-gap-how-online-patient-discussions-can-transform-narcolepsy-care/37657/By listening to and learning from online conversations, providers can better respond to their patients, helping them bridge information gaps and ultimately improve narcolepsy care.- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31298/### Practical Neurology July 2006: Key Advances and InsightsRecent studies and developments in neurology highlight promising advancements and ongoing challenges in patient care. Expanding Acute Stroke Treatment Windows: A Cleveland Clinic trial explored desmoteplase’s efficacy for acute ischemic str
- Waking Up to Opportunities in Sleep Medicinehttps://practicalneurology.com/diseases-diagnoses/sleep/PN0206SleepMed-pdf/31347/Sleep disorders have transitioned from being considered peripheral issues to becoming a fundamental aspect of contemporary neurology practice. Historically overlooked, the intricate relationship between sleep and neurological function gained significant attention in the late 20th century, culminatin
Seeking Breakthroughs: The Industry Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-industry-perspective/30192/A roundtable discussion with Gregory Went, PhD, Adamas Pharmaceuticals; Lynn Kramer, MD, Eisai; Paulo Fontoura, MD, PhD, Genentech/Roche; Justin Gover, BSc, MBA, GW Pharmaceuticals; Marc Kamin, MD, SK Life Sciences; and Mike Davis, BSc, MBA, UCB- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31356/Practical Neurology January 2006 SummaryThe January 2006 issue of *Practical Neurology* highlights significant advancements and challenges within the neurology field, providing valuable insights for healthcare professionals.Subspecialization in Neurology As neuroscience becomes increasingly intrica
Deep Brain Stimulation in Parkinson's Disease: Past, Present, and Future
https://practicalneurology.com/diseases-diagnoses/movement-disorders/deep-brain-stimulation-in-parkinsons-disease-past-present-and-future/30474/Though it has been underutilized over the past two decades, deep brain stimulation is an effective intervention for many individuals with Parkinson's disease.Minimally Invasive Brain Intervention: What all the FUS is About
https://practicalneurology.com/diseases-diagnoses/movement-disorders/minimally-invasive-brain-intervention-what-all-the-fus-is-about/30383/Integrative Care for Patients With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/integrative-care-for-patients-with-multiple-sclerosis/30217/What is integrative care, and why should clinicians care about it?